PLAT and stroke disorder: In 1996, the Food and Drug Administration (FDA) approved intravenous‐tPA (IV‐tPA) for treating acute ischemic stroke, based on successful outcomes in the National Institute of Neurological Disorders and Stroke study.23, 24